Inhibition of acute myeloid leukemia cell growth by mono-specific and bi-specific anti-CD33 x anti-CD64 antibodies

Leukemia Research

Volumn 28, Issue 8, 2004, Pages 821-829

  Balaian, Larisa ^a   Ball, Edward D ^a,b  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bispecific antibodies; CD33 receptor; Myeloid leukemia

Indexed keywords

ANTIBODY; CD33 ANTIBODY; CD64 ANTIBODY; IMMUNOGLOBULIN G2; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; ANTIBODY SPECIFICITY; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER INHIBITION; CELL GROWTH; CELL PROLIFERATION; CELL TRANSPORT; CONTROLLED STUDY; DRUG INHIBITION; DRUG MECHANISM; DRUG POTENCY; HUMAN; HUMAN CELL; LEUKEMIA CELL; MOLECULE; PRIORITY JOURNAL;

ACUTE DISEASE; ANTIBODIES, BISPECIFIC; ANTIGENS, CD; ANTIGENS, DIFFERENTIATION, MYELOMONOCYTIC; CELL DIVISION; HL-60 CELLS; HUMANS; LEUKEMIA, MYELOID; RECEPTORS, IGG; U937 CELLS;

EID: 2942627704     PISSN: 01452126     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.leukres.2003.12.001     Document Type: Article

References (29)

1. Griffin J.D., Linch D., Sabbath K., Larcom P., Schlossman S.F. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Leuk. Res. 8:1984;521-534
2. Ball ED, McDermott, Griffin JD, Davey FR, Davis R, Bloomfield CD. Expression of the three myeloid cell-associated immunoglobulin G Fc receptors defined by murine monoclonal antibodies on normal bone marrow and acute leukemia cells. Blood 1989;73:1951-6.
3. Ball E.D. Immunophenotyping of acute myeloid leukemia cells. Clin. Lab. Med. 110:1990;721-736
4. Applebaum F.R. Antibody-targeted therapy for myeloid leukemia. Semin. Hematol. 36:1999;2-8
5. Fanger M.W., Morganelli P.M., Guyre P.M. Bispecific antibodies. Crit. Rev. Immunol. 12:1992;101-124
6. Chen J., Zhou J.H., Ball E.D. Monocyte-mediated lysis of acute myeloid leukemia cells in the presence of the bispecific antibody. 251×22 (anti-CD33 x anti-CD64) Clin. Cancer Res. 1:1995;1319-1325
7. Glennie M.J., McBride H.M., Worth A.T., Stevenson G.T. Preparation and performance of bispecific F(ab′ gamma) 2 antibody containing thioether linked Fab′ gamma fragments. J. Immunol. 139:1987;2365-2367
8. Ball E.D., Guyre P.M., Mills L., Fisher J., Dinces N.B., Fanger M.W. Initial trial of bispecific antibody-mediated immunotherapy of CD15-bearing tumors: cytotoxicity of human tumor cells using a bispecific antibody comprised of anti-CD15 (MoAb PM81) and anti-CD64/Fc-gamma RI (MoAb32). J. Hematother. 1:1992;85-94
9. Silla L.M., Chen J., Zhong R.K., Whiteside T.M., Ball E.D. Potentiation of lysis of leukemia cells by a bispecific antibody to CD33 and CD16 (Fc gamma RIII) expressed by human natural killer (NK) cells. Br. J. Haematol. 89:1995;712-718
10. Balaian L., Ball E.D. Direct effect of bi-specific anti-CD33 x anti-CD64 antibody on proliferation and signaling in myeloid cells. Leuk. Res. 25:2001;1115-1125
11. Duchemin A.M., Ernst L.K., Anderson C.L. Clustering of the high affinity Fc receptor for immunoglobulin G (Fc gamma RI) results in phosphorylation of its associated gamma chain. J. Biol. Chem. 269:1994;12111-12117
12. Indik Z.K., Park J.G., Hunter S., Schreiber A.D. The molecular dissection of Fc gamma receptor mediated phagocytosis. Blood. 86:1995;4389-4399
13. Wang A.V., Scholl P.R., Geha R.S. Physical and functional association of the high affinity immunoglobulin G receptor (Fc gamma RI) with the kinases Hck and Lyn. J. Exp. Med. 180:1994;1165-1170
14. Pan X.Q., Darby C., Indik Z.K., Schreiber A.D. Activation of three classes of nonreceptor tyrosine kinases following Fc gamma receptor crosslinking in human monocytes. Clin. Immunol. 90:1999;55-64
15. Kiener P.A., Rankin B.M., Burkhardt A.L., Shieven G.L., Gilliard L.K., Rowley R.B., et al. Cross-linking of Fc gamma receptor I (Fc gamma RI) and receptor II (Fc gamma RII) on monocytic cells activated a signal transduction pathway common to both Fc receptors that involves the stimulation of p72 Syk protein tyrosine kinase. J. Biol. Chem. 268:1993;24442-24448
16. Taylor A., Jahn T., Smith S., Lamkin T., Uribe L., Liu J., et al. Differential activation of the tyrosine kinases ZAP-70 and Syk after Fc gamma RI stimulation. Blood. 87:1997;388-396
17. Cambier J.C. Antigen and Fc receptor signaling. The awesome power of the immunoreceptor tyrosine-based activation motif (ITAM). J. Immunol. 155:1995;3281-3285
18. Ulyanova T., Blasioli J., Woodford-Thomas T.A., Thomas M.L. The sialoadhesin CD33 is a myeloid-specific inhibitory receptor. Eur. J. Immunol. 29:1999;3440-3449
19. Taylor V.C., Buckley C.D., Douglas M., Cody A.J., Simmons D.L., Freeman S.D. The myeloid-specific sialic acid-binding receptor, CD33, associates with the protein tyrosine phosphatases, SHP-1 and SHP-2. J. Biol. Chem. 274:1999;11505-11512
20. Paul S.P., Taylor L.S., Stansbury E.K., McVicar D.W. Myeloid specific human CD33 is an inhibitory receptor with differential ITIM function in recruiting the phosphatases SHP-1 and SHP-2. Blood. 96:2000;483-488
21. Darzynkiewicz Z., Gong G., Traganos F. Analysis of DNA content and cyclic protein expression in studies of DNA ploidy, growth fraction, lymphocyte stimulating and the cell cycle Flow Cytometry. Methods Cell Biol. 141:1994;421-435
22. Vitale C., Romagnani C., Falco M., Ponte M., Mingari M.C. Engagement of p75/AIRM-1 or CD33 inhibits the proliferation of normal or leukemic myeloid cells. PNAS. 96:1999;15091-15096
23. Vitale C., Romagnani C., Puccetti A., Olive D., Mingari M.C. Surface expression and function of p75/AIRM-1 or CD33 in acute myeloid leukemias: Engagement of CD33 induces apoptosis of leukemic cells. PNAS. 98:2001;5764-5769
24. Mingari M.C., Vitale C., Romagnani C., Falco M., Moretta L. p75/AIRM-1 and CD33, two sialoadhesin receptors that regulate proliferation or the survival of normal and leukemic myeloid cells. Immunol. Rev. 181:2001;260-268
25. Neppert J., Jungi T.W. Antibodies to human major histocompatibility complex products inhibit Fc gamma receptors types I and II. Transus. Med. 2:1996;125-131
26. Warmerdam P.A., van den Herik-Oudijk I.E., Parren P.W., Westerdaal N.A., van de Winkel J.G., Capel P.J. Interaction of a human Fc gamma RIIb1 (CD32) isoform with murine and human IgG subclasses. Int. Immunol. 3:1993;239-247
27. Balaian L., Zhong R.K., Ball E.D. The inhibitory effect of anti-CD33 monoclonal antibodies on AML cell growth correlates with Syk and/or ZAP-70 expression. Exp. Hematol. 31:2003;363-371
28. Marcilla A., Rivero-Lezcano O.M., Agarwal A., Robbins K.C. Identification of the major tyrosine kinase substrate in signaling complexes formed after engagement of Fc gamma receptor. J. Biol. Chem. 270:1995;9115-9120
29. Brizzi M.F., Rosso A., Dentelli P., Ferrero D., Lanfancne L., Pegoraro L. C-Cbl tyrosine phosphorylation and subcellular localization in human primary leukemia cells. Exp. Hematol. 26:1998;1228-1239